MedTrace Logo

Post-Implant Performance of the EC-3 IOL

NCT01333345 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2011-04-12

No results posted yet for this study

Summary

The purpose of this study is to obtain data on the performance of the EC-3 lens at an interval of two years (and beyond) from subjects who were implanted. The primary aim of the study will be to evaluate the presence, if any, of PCO, lens glistening, and other anomalies in the subjects.

Conditions

  • Cataract

Sponsors & Collaborators

  • Aaren Scientific Inc.

    lead INDUSTRY

Principal Investigators

  • P. Dee G. Stephenson, M.D. · Stephenson Eye Associates

  • N. Timothy Peters, M.D. · Eyesight Ophthalmic Services PA

  • Christophe Pey, M.D. · Cabinet d'Ophtalmologie du Dr. Pey

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01333345 on ClinicalTrials.gov